Lataa...
Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens
FMS-Like-Tyrosine kinase-3 (FLT3) mutations are found in about 30% of cases of acute myeloid leukemia and confer an increased relapse rate and reduced overall survival. Targeting of this tyrosine kinase by direction inhibition is the focus of both preclinical and clinical research in AML. Several mo...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3031857/ https://ncbi.nlm.nih.gov/pubmed/18452067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428190801895352 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|